Efficacy of magnesium in acute myocardial infarction;Stellenwert von Magnesium beim akuten Myokardinfarkt

Zeitschrift fur Kardiologie

Volumn 85, Issue SUPPL. 6, 1996, Pages 129-134

  Beuckelmann, D J ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

acute myocardial infarction; magnesium; mortality

Indexed keywords

FIBRINOLYTIC AGENT; MAGNESIUM;

ACUTE HEART INFARCTION; BLOOD CLOT LYSIS; BRADYCARDIA; CALCIUM CURRENT; CONFERENCE PAPER; DRUG EFFICACY; FLUSHING; HEADACHE; HUMAN; HYPOTENSION; MORTALITY; VERTIGO;

ANIMALS; CALCIUM CHANNELS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HUMANS; INFUSIONS, INTRAVENOUS; MAGNESIUM; MULTICENTER STUDIES; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS; SURVIVAL RATE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 0029908812     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Anderson TW, LeRichc WH, MacKay JS (1969) Sudden death and ischemic heart disease. Correlation with heardness of local water supply. New England Journal of Medicine 280: 805-807
2. Antman EM (1995) Magnesium in acute MI. Timing is critical (Editorial). Circulation 92: 2367-2372
3. Chang C, Varghese PJ, Downey J, Bloom S (1985) Magnesium deficiency and myocardial infarct size in the dog. Journal of the American College of Cardiology 5: 280-289
4. Christensen CW, Rieder MA, Silverstein EL, Gencheff NE (1995) Magnesium supfate reduces myocardial infarct size when administered before but not after coronary reperfusion in a canine model. Circulation 92: 2617-2621
5. Haigney MCP, Silver B, Tanglao E, Silverman HS, Hill JD, Shapiro E, Gerstenblith G, Schulman SP (1995) Noninvasive measurement of tissue magnesium and correlation with cardiac levels. Circulation 92: 2190-2197
6. Herzog WR, Schlossberg ML, MacMurphy KS, Edenbaum LR, Gerber MJ, Vogel RA, Serebruany VI (1995) Timing of magnesium therapy affects experimental infarct size. Circulation 92: 2622-2626
7. Horner SM (1992) Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality. Circulation 86: 774-779
8. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group (1995) ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate. and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet 345: 669-685
9. Jennings RB, Schaper J, Hill ML, Steenbergen C jr, Reimer KA (1985) Effect of reperfusion late in the phase of reversible ischemic injury. Circulation Research 56: 1089-1104
10. Marban E, Kitakaze M, Koretsune Y, Yue DT, Chacko VP, Pike MM (1990) Quantification of [Ca2+]i in perfused hearts. Critical evaluation of the 5F-BAPTA and nuclear magnetic resonance method as applied to the study of ischemia and reperfusion. Circulation Research 66: 1255-1267
11. Pike MM, Kitakaze M, Marban E (1988) Increase in intracellualr free sodium concentration during ischemia revealed by 23Na NMR in perfused ferret hearts (abstract). Circulation 78 (suppl II): II-151
12. Reeder GS (1995) Adjuctive therapy in the management of patients with acute myocardial infarction. Mayo Clinics Proceedings 70: 464-468
13. Schlack W, Bier F, Schäfer M, Uebing A, Schäfer S, Borchard U,Thämer V (1995) Intracoronary magnesium is not protective against acute reperfusion injury in the regional ischaemic-reperfused dog heart. European Journal of Clinical Investigation. 25: 501-509
14. Woods KL, Fletscher S, Roffe C, Haider Y (1992) Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention trial (LIMIT-2). Lancet 339: 1553-1558
15. Woods KL, Fletscher S (1994) Long-term outcome after intravenous magnesium sulphate in suspected myocardial infarction: the second Leicester Intravenous Magnesium Intervention trial (LIMIT-2). Lancet 343: 816-819